Investigation of wearable health tracker version updates by Woolley, S et al.
 1Woolley SI, et al. BMJ Health Care Inform 2019;26:e100083. doi:10.1136/bmjhci-2019-100083
Open access 
Investigation of wearable health tracker 
version updates
Sandra I Woolley  ,1 Tim Collins,2 James Mitchell  ,1 David Fredericks1
To cite: Woolley SI, 
Collins T, Mitchell J, et al.  
Investigation of wearable 
health tracker version updates. 
BMJ Health Care Inform 
2019;26:e100083. doi:10.1136/
bmjhci-2019-100083
Received 03 June 2019
Revised 29 August 2019
Accepted 16 September 2019
1School of Computing and 
Mathematics, Keele University, 
Keele, UK
2Department of Engineering, 
Manchester Metropolitan 
University, Manchester, UK
Correspondence to
Dr Sandra I Woolley;  
 s. i. woolley@ keele. ac. uk
Short report
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
background Wearable fitness trackers are increasingly 
used in healthcare applications; however, the frequent 
updating of these devices is at odds with traditional 
medical device practices.
Objective Our objective was to explore the nature and 
frequency of wearable tracker updates recorded in device 
changelogs, to reveal the chronology of updates and to 
estimate the intervals where algorithm updates could 
impact device validations.
Method Updates for devices meeting selection 
criteria (that included their use in clinical trials) were 
independently labelled by four researchers according to 
simple function and specificity schema.
results Device manufacturers have diverse approaches 
to update reporting and changelog practice. Visual 
representations of device changelogs reveal the nature 
and chronology of device iterations. 13% of update items 
were unspecified and 32% possibly affected validations 
with as few as 5 days between updates that may affect 
validation.
Conclusion Manufacturers could aid researchers and 
health professionals by providing more informative device 
update changelogs.
IntrOduCtIOn
Wearable consumer activity monitors have 
substantially increased in popularity in the 
last decade,1 and are increasingly used in 
healthcare applications and clinical trials. 
The US clinical trials database,  ClinicalTrials. 
gov, returns 273 intervention results for 
‘Fitbit’ (search accessed 30 May 2019) for 
a spectrum of studies investigating disease 
biomarkers, monitoring patient progress 
and incentivising lifestyle improvements. 
For example, studies include lifestyle inter-
ventions for overweight postpartum women 
(NCT03826394) and older adults at risk of 
cardiovascular disease (NCT03720327), a 
study with bowel disease patients to inves-
tigate biomarkers for predicting relapse 
(NCT03953794) and a study assessing reha-
bilitation progress of patients following knee 
surgery (NCT03368287).
The consumer fitness tracker market is fast-
changing. New device models are regularly 
introduced and updated, and old models are 
retired. For example, the Garmin Vivosmart 
‘family’ of wrist-worn activity trackers have 
included five physically distinct ‘models’: the 
(original) Vivosmart in 2014, Vivosmart HR 
in 2015 (which included optical heart rate 
sensing), Vivosmart HR+ in 2016, Vivosmart 3 
in 2017 and Vivosmart 4 in 2018, all of which 
received several updates.
Wrist-worn trackers have increasingly 
supplemented step counting, activity moni-
toring, energy expenditure, sleep tracking 
and stress estimation with optical heart 
rate sensing from photoplethysmography 
sensors.2 There is some debate about the reli-
ability of these devices and their heart rate 
estimation,3 and device validation studies have 
reached different conclusions for different 
health and exercise scenarios.4–6 However, 
the devices can, and do, achieve significantly 
improved user activity behaviours and health 
outcomes.7 These positive health effects have 
incentivised efforts towards new applications 
in corporate wellness,8 health insurance9 and 
in an increasing spectrum of clinical studies 
and patient-monitoring applications.10 11 But, 
despite this move towards healthcare appli-
cations, device manufacturers are clear 
that their products are not medical devices. 
Indeed, the certification processes and vali-
dation timescales of medical devices are 
wholly at odds with the ‘iterative character-
istics’ of consumer devices that can regularly 
and automatically update. At the launch of 
a pilot device manufacturer pre-certification 
programme aimed at addressing this gap, 
US Food and Drug Administration Commis-
sioner Scott Gottlieb stated that ‘Our method 
for regulating digital health products must recog-
nize the unique and iterative characteristics of 
these products’.12 This ‘iterative’ nature also 
applies to device algorithms as manufac-
turers attempt to improve both parameter 
estimation and user satisfaction. So, not 
only does the appearance and behaviour of 
the devices update, but also the algorithms 
used in the logging and reporting of their 
data. These changes are made to the code 
that runs inside the processors embedded 
within these devices. In general, ‘embedded 
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box 1 selection criteria for trackers
 ► Consumer-grade wrist-worn fitness tracker device designed for 
adult use.
 ► Includes heart rate sensing.
 ► Device family currently available.
 ► Model available for at least 12 months between 01 January 2017 
and 01 April 2019.
 ► Manufacturer maintains a changelog.
 ► Device model specified in at least one clinical trial.
box 2 update type labels
 ► Bug fix
 ► Issue resolution
 ► Feature/function addition
 ► Feature/function improvement
 ► Algorithm adjustment
 ► User interface change
 ► Removal of items
 ► Security
specificity Labels:
 ► Specified
 ► Semi-specified
 ► Unspecified
Estimated Potential to Impact on Validation Labels:
 ► Yes
 ► Possibly
 ► Probably not
 ► No
systems’ are products or systems that contain embedded 
computer intelligence for purposes other than gener-
al-purpose computing. Today, most electronic products 
are embedded systems and, increasingly, in the age of the 
Internet of the Things (IoT), embedded system firmware 
updates can be communicated and applied automatically, 
without user intervention. Embedded code, being closer 
to the hardware of a system, is referred to as ‘firmware’. 
Changes to device firmware can alter devices in funda-
mental ways. For example, by changing the rate and accu-
racy at which sensor signals are sampled, by changing the 
selection and filtering of signals, by changing algorithms 
that estimate measurements, such as heart rate and step 
count, and by selectively reporting and recording the 
results. From consumer goods, such as microwave ovens 
and washing machines, to mobile phones, cars and aero-
planes, devices can all be re-versioned with new firmware. 
Ideally, changes to firmware are recorded and itemised 
in a changelog document. Of course, manufacturers of 
commercial goods are under no obligation to share the 
details of their proprietary algorithms or reveal their 
intellectual property. Yet, at the same time, a level of open 
reporting can benefit users, stakeholders and, potentially, 
the manufacturers themselves.
It is noteworthy that, beyond firmware updates, there 
are additional software iteration complexities. IoT devices, 
such as wearables and smart home devices, can have their 
own operating systems and are often supported by cloud 
software services and interacted with via companion 
‘apps’. Updates to these other software components 
can also substantively impact device behaviour and data 
reporting.
The analysis of software code-related data and reposito-
ries is a mature field of research, but the focus has been 
on version control systems, such as GitHub,13 open-source 
repositories and archives of user and developer fora.14 15 
There have been no analyses of consumer fitness tracking 
device repositories or changelogs. This may be due to 
several factors including the absence of source code and 
developer community engagements, the transient nature 
of device models or the relative sparsity of data in forum 
communications and device changelogs.
The neglect of updates in the literature has been 
reported by Vitale et al,16 who observed, regarding the 
design of software updates, that ‘no prior study can be found 
that investigated users’ opinions regarding various design alter-
natives’. In relation to operating system updates, Fagan et 
al17 make several recommendations for improvement. For 
example, enabling updates to be reversible and decou-
pling security updates from other updates so that security 
updates can be made regularly, and other updates made 
selectively. They also recommend transparency to enable 
users to give consent to substantive changes. Beyond the 
academic literature, there are software developer and 
user experience (UX) designer opinions regarding best 
practice.18–20 While style preferences vary, in general, 
the advice posited is (i) maintenance of a changelog, 
(ii) dating of updates, (iii) the grouping or labelling of 
updates according to type or impact and (iv) making 
appropriate levels of details available to readers.
MEthOds And AnALysIs
By searching the US Library of Medicine  ClinicalTrials. 
gov database (search accessed 30 May 2019) with all 
device manufacturer names and models, we identified 
instances of named models of wearable heart rate sensing 
fitness trackers in patient studies. We then applied the 
device criteria listed in box 1 to select device models.
Changelogs were retrieved for tracker models meeting 
the selection criteria. Missing update release dates were 
extracted from manufacturer and user fora messages. 
Four researchers independently labelled each update 
item (updates typically comprise several items) according 
to type, specificity and potential to impact validation 
using the simple schema summarised in box 2. Differ-
ences in item labels were resolved by majority and arbitra-
tion. The type labelling scheme was based on the popular 
practice of added, changed, deprecated, removed, fixed 
and security labelling.20 ‘Bug fix’ and ‘issue resolution’ 
items are frequently distinguished in update items, and 
so were provided with different labels. Similarly, ‘addi-
tion’ and ‘improvement’ changes were provided with 
distinct labels as were ‘user interface change’ items to 
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Figure 1 Update bar charts for each model for (i) type, (ii) specificity and (iii) estimated potential to affect validation.
distinguish device presentation and interaction changes 
from other changes. A specific change label for ‘algo-
rithm adjustment’ was used to reveal functional changes 
that more evidently affect data recording and validation, 
for example, ‘Improvements to calculating resting heart rate’.
rEsuLts
Six device models met the selection criteria: the Fitbit 
Charge 2 (used in twenty-nine studies listed at  Clinical-
Trials. gov), Fitbit Charge 3 (used in four studies), Polar 
A370 (used in one study), Garmin Vivosmart 3 (used in 
two studies), Garmin Vivosmart 4 (used in one study) 
and Garmin Vivosport (used in one study). Only Polar’s 
changelog included dates. The update types, specificity 
and potential to impact validation for each of the six 
models are summarised in bar charts in figure 1. The 
chronology for types, specificity and potential to impact 
validation is illustrated in figure 2.
In total, the six device model changelogs comprised 194 
update items. Overall, 13% of updates were unspecified 
and 32% possibly affected device validations. Maximum 
and minimum intervals between updates possibly 
affecting validations were 218 and 5 days, respectively.
Overall, user interface change updates accounted for 
18% of all update items and the feature/function changes 
(additions and improvements) accounted for 33.5%. 
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Figure 2 Update chronology for (i) type, (ii) specificity and (iii) estimated potential to affect validation.
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Together, bug fixes and issue resolutions accounted for 
35% and the percentage of algorithm adjustment updates 
was 12%. Only one update was identified as a security 
update and only two updates were identified as item 
removals.
dIsCussIOn
Although  ClinicalTrials. gov returned 273 intervention 
results for ‘Fitbit’, only 38 studies satisfied the selection 
criteria. Many studies were excluded because they did not 
meet the adult heart rate sensing or device availability 
criteria, or because they failed to identify device models. 
It is noteworthy that activity tracking studies cannot easily 
be enumerated because there is no labelling schema and 
there is a lack of consistency in terminology. For example, 
studies refer variously and ambiguously to devices by 
manufacturer name alone, for example, ‘Fitbit’, or gener-
ically as ‘activity tracker’, ‘activity monitor’, ‘smartwatch’, 
‘wearable sensor’, and so on. We identified trials meeting 
our selection criteria by searching for all manufacturer 
and model names. But, ideally, trials would be labelled 
according to some useful schema.
Of course, researchers may do well to avoid specific 
device details at the proposal stage of their clinical trials 
because, by the time of recruitment, the specified models 
may be unavailable and newer and more functional 
models may be available. But, at the same time, trial docu-
mentation would ideally provide a more meaningful level 
of information about study materials. Perhaps, if trial 
devices can be upgraded and updated post-proposal, then 
trial documentation should be updated also? Perhaps the 
consequence of ‘iterative’ devices is the need for iterative 
documentation?
All the device changelogs in our study contained some 
entries that were difficult or impossible to confidently 
classify. Of course, device updates may fit several catego-
ries, for example, a bug fix could be a security update 
and a new feature could be an interface change, and 
so on. But it should still be possible to label and specify 
items. Common unspecified items included ‘various 
other updates’ and ‘bug fixes’ which do not indicate the 
number of changes and their potential to impact recorded 
data. Ambiguous entries like these may not be considered 
problematic for consumer-grade devices but, when the 
same devices are used for scientific research, the impact 
of an update on device performance and validation could 
be significant. As manufacturers increasingly promote 
the use of devices in research and health-related applica-
tions, there may be more incentives for the maintenance 
of accurate and unambiguous changelogs.
Alongside the need for accurate changelogs and study 
descriptions, there is a wider need to more accurately 
report device models and version numbers in the litera-
ture.21 It should be important to verify that devices are 
used at the same version that they were validated at, 
and that the version number is reported in the inter-
ests of repeatability. Version numbers for statistical 
analysis software are often reported for this reason, but 
the reporting of device firmware versions is almost always 
neglected. Because devices can update automatically 
during data synchronisation, it is likely that firmware 
updates are often applied inadvertently in the middle of 
studies without the researcher noticing or reporting the 
change.
Ideally, there would be a better awareness of device 
versioning, and device versions would be controlled or 
at least reported in study and research literature. Manu-
facturers could also benefit the community by providing 
accessible changelog details and labelling appropriate for 
research and healthcare users and, perhaps, supported by 
simple visual bar chart and chronology summaries similar 
to those reported in figures here.
COnCLusIOns
We observed striking differences between manufacturer 
changelog practices. For example, differences in level of 
detail, in voice and presentation style, and in the inclu-
sion and omission of date information. Ideally, manufac-
turers would adhere to informative and consistent (and, 
perhaps, standardised) changelog formats that provide 
useful and accessible information to clinical researchers 
and healthcare professionals. For example, by labelling 
updates according to type, highlighting key functional/
algorithm change updates and avoiding unspecified 
entries and ambiguous update descriptions. There is also 
a need for version reporting in the wearable monitoring 
literature and an improved awareness that firmware 
updates can nullify device validations.
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